...
首页> 外文期刊>Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research >Characterization of bioactive compounds and ameliorative effects of Ceratonia siliqua leaf extract against CCl induced hepatic oxidative damage and renal failure in rats.
【24h】

Characterization of bioactive compounds and ameliorative effects of Ceratonia siliqua leaf extract against CCl induced hepatic oxidative damage and renal failure in rats.

机译:大麦角藤提取物的生物活性化合物表征和改善CCl诱导的大鼠肝氧化损伤和肾衰竭的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Ceratonia siliqua is a typical Mediterranean plant, mainly used in food and Tunisian traditional folk medicine. Among the tested extracts, the ethyl acetate fraction (EACs) exhibited the highest total phenolic and flavonoids content. The antioxidant activity in vitro systems showed a more significant potent free radical scavenging activity of this extract than other analysis fractions. The HPLC finger print of EACs active extract showed the presence of six phenolic compounds. The in vivo results showed that oral administration of CCl(4) enhanced levels of hepatic and renal markers (ALT, AST, ALP, LDH, gamma-GT, urea and creatinine) in the serum of experimental animals. It also increased the oxidative stress markers resulting in increased levels of the lipid peroxidation with a concomitant decrease in the levels of enzymatic antioxidants (SOD, CAT, GPx) in both liver and kidney. The pre-treatment of experimental rats with 250 mg/kg (BW) of the EACs, by intraperitoneal injection for 8 days, prevented CCl(4) induced disorders in the levels of hepatic and kidney markers. The biochemical changes were in accordance with histopathological observations suggesting a marked hepatoprotective and nephroprotective effect of the EACs extract.
机译:Ceratonia siliqua是一种典型的地中海植物,主要​​用于食品和突尼斯传统民间医学。在测试的提取物中,乙酸乙酯馏分(EACs)表现出最高的总酚和类黄酮含量。体外系统中的抗氧化剂活性显示该提取物比其他分析组分具有更显着的有效自由基清除活性。 EACs活性提取物的HPLC指纹图谱显示存在六种酚类化合物。体内结果显示,口服CCl(4)可以提高实验动物血清中肝和肾标志物(ALT,AST,ALP,LDH,γ-GT,尿素和肌酐)的水平。它还增加了氧化应激标志物,导致脂质过氧化水平增加,同时肝脏和肾脏中的酶促抗氧化剂(SOD,CAT,GPx)水平也随之下降。通过腹腔注射8天用250 mg / kg(BW)的EAC预处理实验大鼠,可预防CCl(4)诱导的肝和肾标志物水平紊乱。生化变化与组织病理学观察一致,表明EACs提取物具有明显的肝保护和肾保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号